Basaglar

Active Ingredient(s): Insulin Glargine
FDA Approved: * December 16, 2015
Pharm Company: * ELI LILLY AND CO
Category: Diabetes

Insulin glargine [GLAR geen], sold under the brand name Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes.[6] It is typically the recommended long acting insulin in the United Kingdom.[7][contradictory] It is used once a day as an injection just under the skin.[6] Effects generally begin an hour after use.[6] Common side effects include low blood sugar, problems a... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Basaglar 100 [Iu]/Ml Subcutaneous Injection, Solution
NDC: 0002-7711
Labeler:
Eli Lilly and Company
Basaglar 100 [Iu]/Ml Subcutaneous Injection, Solution
NDC: 0002-7715
Labeler:
Eli Lilly and Company

Related Brands

Drugs with the same active ingredients

Popular Topics

Invocana, Victosa and Basaglar negative reactions

I am a type 2 diabetic and I'm taking other diabetic meds along with Invocana. I'm taking other meds, such as Ba...

1 REPLY